Monoclonal Antibody Preparation against the Hemolysin of Actinobacillus Pleuropneumoniae

碩士 === 國立中興大學 === 獸醫學系 === 82 === The objective of this study is to prepare monoclonal antibodies (MAbs) against the hemolysin of Actinobacillus pleuropneumoniae (A.P.) serotype 1 (HylI). These MAbs were then used in the injection...

Full description

Bibliographic Details
Main Authors: Liang, Judging, 梁嘉君
Other Authors: Chen, San Duo
Format: Others
Language:zh-TW
Published: 1994
Online Access:http://ndltd.ncl.edu.tw/handle/69512808151164258821
id ndltd-TW-082NCHU0541005
record_format oai_dc
spelling ndltd-TW-082NCHU05410052015-10-13T15:33:32Z http://ndltd.ncl.edu.tw/handle/69512808151164258821 Monoclonal Antibody Preparation against the Hemolysin of Actinobacillus Pleuropneumoniae 胸膜肺炎放線桿菌溶血素單株抗體之製作 Liang, Judging 梁嘉君 碩士 國立中興大學 獸醫學系 82 The objective of this study is to prepare monoclonal antibodies (MAbs) against the hemolysin of Actinobacillus pleuropneumoniae (A.P.) serotype 1 (HylI). These MAbs were then used in the injection of mice, to assess their protection activity against A.P. challenge. The spleens of BALB/c mice had been immunized 4 times with purified HylI and showed very strong antibody response.These spleen cells were then fused with P3x myeloma cells. When screening test for specific antibodies production using the ELISA test, 24 out of 880 wells showed strong positive reactions. Subsequently 3 consecutive subclonings had established 9 strains of hybridoma with stable activities of MAbs secretion. Two strains among them with resist-hemolytic reactions injected mice. When comparing those immunized mice with those have been immunized by the bacteria, the survival ratio was 8:5 after the A.P. challenge. Whereas the contral groups (immunized with PBS) were killed after the challenge. Those challenge bacteria could be recovered from the lungs of dead mice. Chen, San Duo 陳三多 1994 學位論文 ; thesis 83 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 碩士 === 國立中興大學 === 獸醫學系 === 82 === The objective of this study is to prepare monoclonal antibodies (MAbs) against the hemolysin of Actinobacillus pleuropneumoniae (A.P.) serotype 1 (HylI). These MAbs were then used in the injection of mice, to assess their protection activity against A.P. challenge. The spleens of BALB/c mice had been immunized 4 times with purified HylI and showed very strong antibody response.These spleen cells were then fused with P3x myeloma cells. When screening test for specific antibodies production using the ELISA test, 24 out of 880 wells showed strong positive reactions. Subsequently 3 consecutive subclonings had established 9 strains of hybridoma with stable activities of MAbs secretion. Two strains among them with resist-hemolytic reactions injected mice. When comparing those immunized mice with those have been immunized by the bacteria, the survival ratio was 8:5 after the A.P. challenge. Whereas the contral groups (immunized with PBS) were killed after the challenge. Those challenge bacteria could be recovered from the lungs of dead mice.
author2 Chen, San Duo
author_facet Chen, San Duo
Liang, Judging
梁嘉君
author Liang, Judging
梁嘉君
spellingShingle Liang, Judging
梁嘉君
Monoclonal Antibody Preparation against the Hemolysin of Actinobacillus Pleuropneumoniae
author_sort Liang, Judging
title Monoclonal Antibody Preparation against the Hemolysin of Actinobacillus Pleuropneumoniae
title_short Monoclonal Antibody Preparation against the Hemolysin of Actinobacillus Pleuropneumoniae
title_full Monoclonal Antibody Preparation against the Hemolysin of Actinobacillus Pleuropneumoniae
title_fullStr Monoclonal Antibody Preparation against the Hemolysin of Actinobacillus Pleuropneumoniae
title_full_unstemmed Monoclonal Antibody Preparation against the Hemolysin of Actinobacillus Pleuropneumoniae
title_sort monoclonal antibody preparation against the hemolysin of actinobacillus pleuropneumoniae
publishDate 1994
url http://ndltd.ncl.edu.tw/handle/69512808151164258821
work_keys_str_mv AT liangjudging monoclonalantibodypreparationagainstthehemolysinofactinobacilluspleuropneumoniae
AT liángjiājūn monoclonalantibodypreparationagainstthehemolysinofactinobacilluspleuropneumoniae
AT liangjudging xiōngmófèiyánfàngxiàngǎnjūnróngxuèsùdānzhūkàngtǐzhīzhìzuò
AT liángjiājūn xiōngmófèiyánfàngxiàngǎnjūnróngxuèsùdānzhūkàngtǐzhīzhìzuò
_version_ 1717766668687507456